Electrospinning growth factor releasing microspheres into fibrous scaffolds

J Vis Exp. 2014 Aug 16:(90):51517. doi: 10.3791/51517.

Abstract

This procedure describes a method to fabricate a multifaceted substrate to direct nerve cell growth. This system incorporates mechanical, topographical, adhesive and chemical signals. Mechanical properties are controlled by the type of material used to fabricate the electrospun fibers. In this protocol we use 30% methacrylated Hyaluronic Acid (HA), which has a tensile modulus of ~500 Pa, to produce a soft fibrous scaffold. Electrospinning on to a rotating mandrel produces aligned fibers to create a topographical cue. Adhesion is achieved by coating the scaffold with fibronectin. The primary challenge addressed herein is providing a chemical signal throughout the depth of the scaffold for extended periods. This procedure describes fabricating poly(lactic-co-glycolic acid) (PLGA) microspheres that contain Nerve Growth Factor (NGF) and directly impregnating the scaffold with these microspheres during the electrospinning process. Due to the harsh production environment, including high sheer forces and electrical charges, protein viability is measured after production. The system provides protein release for over 60 days and has been shown to promote primary nerve cell growth.

Publication types

  • Research Support, Non-U.S. Gov't
  • Video-Audio Media

MeSH terms

  • Animals
  • Cell Growth Processes / drug effects
  • Cell Growth Processes / physiology
  • Chick Embryo
  • Ganglia, Spinal / cytology*
  • Hyaluronic Acid / chemistry
  • Lactic Acid / chemistry
  • Microspheres*
  • Nerve Growth Factor / administration & dosage
  • Nerve Growth Factor / chemistry*
  • Neurons / cytology*
  • Polyglycolic Acid / chemistry
  • Polylactic Acid-Polyglycolic Acid Copolymer
  • Tissue Engineering / methods*
  • Tissue Scaffolds*

Substances

  • Polylactic Acid-Polyglycolic Acid Copolymer
  • Polyglycolic Acid
  • Lactic Acid
  • Hyaluronic Acid
  • Nerve Growth Factor